Altogether, these data indicate that Tat and IC synergize in promoting KS development and progression and that IC-treated BKV/Tat transgenic mice represent a suitable model to test interventions against AIDS-KS, although it does not allow the evaluation of HHV8-promoted oncogenesis. This evidence concerns the gene TAT and Kaposi's sarcoma.